Literature DB >> 6252950

An outbreak of adenovirus type 4 conjunctivitis.

A B Tullo, P G Higgins.   

Abstract

An unusually large outbreak of conjunctivitis caused by adenovirus type 4 involved 113 proved cases during a 7-month period. Though the disease was less severe than is commonly seen in epidemic keratoconjunctivitis caused by other serotypes, the cornea was affected in 23% of cases and symptoms persisted for at least 5 weeks in 6 patients. A concurrent increase in nonocular adenovirus type 4 infections in the Bristol area was not observed. Nine of the cases could have arisen as a result of hospital cross-infection.

Entities:  

Mesh:

Year:  1980        PMID: 6252950      PMCID: PMC1043745          DOI: 10.1136/bjo.64.7.489

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  EPIDEMIC KERATOCONJUNCTIVITIS ON TAIWAN: ETIOLOGICAL AND CLINICAL STUDIES.

Authors:  J T GRAYSTON; Y F YANG; P B JOHNSTON; L S KO
Journal:  Am J Trop Med Hyg       Date:  1964-05       Impact factor: 2.345

2.  A hemagglutination-inhibition technique for typing adenoviruses.

Authors:  L ROSEN
Journal:  Am J Hyg       Date:  1960-01

3.  Pharyngo-conjunctival fever; school outbreaks in England during the summer of 1955 associated with adenovirus types 3, 7, and 14.

Authors:  E J KENDALL; R W RIDDLE; H A TUCK; K S RODAN; B E ANDREWS; J C MCDONALD
Journal:  Br Med J       Date:  1957-07-20

4.  Recovery of new agent from patients with acute respiratory illness.

Authors:  M R HILLEMAN; J H WERNER
Journal:  Proc Soc Exp Biol Med       Date:  1954-01

5.  Acute haemorrhagic conjunctivitis during an epidemic outbreak of adenovirus-type-4 injection.

Authors:  A Muzzi; G Rocchi; B Lumbroso; G Tosato; F Barbieri
Journal:  Lancet       Date:  1975-10-25       Impact factor: 79.321

6.  An outbreak of adenovirus keratoconjunctivitis in bristol.

Authors:  A B Tullo; P G Higgins
Journal:  Br J Ophthalmol       Date:  1979-09       Impact factor: 4.638

7.  Outbreak in Bristol of conjunctivitis caused by adenovirus type 8, and its epidemiology and control.

Authors:  D L Barnard; J C Hart; V J Marmion; S K Clarke
Journal:  Br Med J       Date:  1973-04-21
  7 in total
  8 in total

1.  Genomic characterization of human adenovirus type 4 strains isolated worldwide since 1953 identifies two separable phylogroups evolving at different rates from their most recent common ancestor.

Authors:  Gabriel Gonzalez; Camden R Bair; Daryl M Lamson; Hidemi Watanabe; Laura Panto; Michael J Carr; Adriana E Kajon
Journal:  Virology       Date:  2019-09-08       Impact factor: 3.616

2.  Genetic heterogeneity of recent isolates of adenovirus types 3, 4, and 7.

Authors:  A S Bailey; S J Richmond
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

Review 3.  Enteroviral conjunctivitis and its neurological complications.

Authors:  P G Higgins
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

4.  Surveillance and control of epidemic keratoconjunctivitis.

Authors:  J D Gottsch
Journal:  Trans Am Ophthalmol Soc       Date:  1996

5.  New genome type of adenovirus serotype 4 caused nosocomial infections associated with epidemic conjunctivitis in Japan.

Authors:  Toshihide Ariga; Yasushi Shimada; Kazuhiro Ohgami; Yoshitsugu Tagawa; Hiroaki Ishiko; Koki Aoki; Shigeaki Ohno
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

6.  Adenovirus serotypes isolated from ocular infections in London.

Authors:  S Darougar; P Walpita; U Thaker; N Viswalingam; L Gardner; D A McSwiggan
Journal:  Br J Ophthalmol       Date:  1983-02       Impact factor: 4.638

7.  Clinical and aetiological study of adenoviral conjunctivitis, with special reference to adenovirus types 4 and 19 infections.

Authors:  K Aoki; M Kato; H Ohtsuka; K Ishii; N Nakazono; H Sawada
Journal:  Br J Ophthalmol       Date:  1982-12       Impact factor: 4.638

8.  Clinical and epidemiological features of adenovirus keratoconjunctivitis in London.

Authors:  S Darougar; R H Grey; U Thaker; D A McSwiggan
Journal:  Br J Ophthalmol       Date:  1983-01       Impact factor: 4.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.